MIT begins building Pfizer facility
Research at Kendall Square site will focus on drugs for diabetes, Alzheimer’s
Pfizer Inc. on Monday will add its name to an ever-growing list of corporate giants moving to the outskirts of the Massachusetts Institute of Technology, where it will kick off construction of a new research complex. The company is planning to move into a 230,000-square-foot building to be developed at 610 Main St., where it will launch research operations focused on developing cures for illnesses ranging from type 2 diabetes, to alzheimer’s, to schizophrenia. About 400 employees will work in the building.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
